# LEANOX (NCT03255434)

> LEAn Body Mass Normalization of OXaliplatin Based Chemotherapy

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT03255434
- Phase: PHASE2
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle
- Conditions: Stage III Colon Cancer
- Interventions: Oxaliplatin; Oxaliplatin LBM
- Enrollment: 160
- Primary outcome: Evaluation of neurotoxicity associated with Oxaliplatin

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- X threads: 10
- Podcasts: 1

## Order

Standard, $1,250, price fixed at order: https://www.erudio.com/contact?report=leanox-nct03255434

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT03255434", "email": "<work email>"}; the inbox owner confirms by the emailed link.